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Abstract
Background: Clinicians use various clinical reasoning tools such as Ishikawa diagram to enhance their clinical
experience and reasoning skills. Failure mode and effects analysis, which is an engineering methodology in origin,
can be modified and applied to provide inputs into an Ishikawa diagram.
Method: The human biliary system is used to illustrate a modified failure mode and effects analysis. The anatomical
and physiological processes of the biliary system are reviewed. Failure is defined as an abnormality caused by
infective, inflammatory, obstructive, malignancy, autoimmune and other pathological processes. The potential failures,
their effect(s), main clinical features, and investigation that can help a clinician to diagnose at each anatomical part
and physiological process are reviewed and documented in a modified failure mode and effects analysis table.
Relevant medical and surgical cases are retrieved from the medical literature and weaved into the table.
Results: A total of 80 clinical cases which are relevant to the modified failure mode and effects analysis for the human
biliary system have been reviewed and weaved into a designated table. The table is the backbone and framework for
further expansion. Reviewing and updating the table is an iterative and continual process. The relevant clinical features
in the modified failure mode and effects analysis are then extracted and included in the relevant Ishikawa diagram.
Conclusions: This article illustrates an application of engineering methodology in medicine, and it sows the seeds of
potential cross-pollination between engineering and medicine. Establishing a modified failure mode and effects
analysis can be a teamwork project or self-directed learning process, or a mix of both. Modified failure mode and
effects analysis can be deployed to obtain inputs for an Ishikawa diagram which in turn can be used to enhance
clinical experiences and clinical reasoning skills for clinicians, medical educators, and students.
Main text
Clinicians, medical educators, and medical students use
various clinical reasoning tools such as Ishikawa diagram
(which is also known as “cause-and-effect diagram”) to en-
hance their clinical experience and reasoning skills. The
methodology of applying an Ishikawa diagram in a clinical
setting is illustrated in another article [1]. The methods
that can be applied to gather information for an Ishikawa
diagram include brain storming, focus group discussion,
interview, survey, and literature searches and review are
discussed in a book chapter [2]. This article illustrates how
to modify and apply failure mode and effects analysis
(FMEA) to provide inputs into an Ishikawa diagram which
in turn can be used as a clinical reasoning tool.
FMEA is a tool developed by engineers to systematically
assess a complex design or process in order to identify
elements that have a risk of failure [3]. In the late 1940s,
FMEA was established and deployed by reliability engi-
neers to identify potential failures in military systems [4].
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Simplistically, the FMEA approach includes a meticulous
study on the mode or mechanism by which a failure may
occur and the effect(s) that it may cause. The severity of
the effect (S), the probability of a failure occurring (O),
and the probability that the failure would not be detected
(D), are computed or estimated. Then, a risk priority
number (RPN) is calculated by multiplying S, O, and D.
The RPN is then used to prioritize the remedial and/or
preventive measures. The FMEA approach is an ongoing
iterative process. It should be updated when there is a
change in the process or design, or when there is a failure
or when a near-miss failure occurs. The ultimate objective
of an FMEA is to provide a platform for the prevention,
or at least reduce the likelihood and improve the detec-
tion, of failure in a system.
How can I relate this engineering approach to an appli-
cation in medicine? In this article, failure is defined as an
abnormality caused by infective, inflammatory, obstructive,
malignancy, autoimmune and other pathological processes.
I may not be able to relate the FMEA approach to the en-
tirety of a complex human being with multidimensional
complexities including psychosocial components, when an
individual presents with a clinical manifestation (that is, a
“failure”). Nonetheless, I am illustrating an application of
the FMEA approach to a specific subsystem in a human.
The “design or anatomy” of a human body and its under-
lying physiological processes have a potential risk of failing
at its various parts anatomically and physiologically. The
effect(s) of the failure could be manifested as clinical
features (symptoms and signs). The severity, occurrence,
and detection of the failure are complex and difficult to be
estimated to compute a RPN. Hence, I am excluding RPN
in this FMEA approach which I call a “modified FMEA”
(in short, mFMEA). The ultimate objective of mFMEA is
to provide a methodology to clinicians, medical educators,
and medical students, to integrate in their clinical reason-
ing process and to deploy relevant clinical cases to set the
scenario for teaching and learning a specific topic.
The mFMEA approach is applicable for general practi-
tioners (GPs)/family physicians, specialists in various fields
(internal medicine, surgery, emergency, intensive care, and
so on), medical educators, and medical students. The
bottom line is that a patient will always present with
symptoms and signs (clinical features or syndromes) that
need to be analyzed and put in perspective in an individu-
alized context. An experienced clinician such as a
physician or specialist may reach a spot diagnosis or
provisional diagnosis, and manage the patient accordingly
in a reasonably efficient timeframe. In an experienced
diagnostician, the clinical reasoning and diagnostic skill
seem to have become second nature to him/her, and the
skills may not be explicit to an observer. However, a junior
clinician or medical student may start from the first
principle to work out a list of differential diagnoses using
various clinical reasoning tools such as brain storming,
mind mapping, and the Ishikawa diagram/fishbone dia-
gram or cause-and-effect diagram [1]. For example, if a
patient presents with a main complaint of pain in the right
upper quadrant (RUQ) of the abdomen, a clinician will
have a list of differential diagnoses including cholecystitis,
cholelithiasis, hepatitis, peptic ulcer, pancreatitis, and
referred pain. These can be illustrated in an Ishikawa
diagram (Fig. 1) which is subject to ongoing update. The
Ishikawa diagram comprises “gastroenterology”, “other
systems”, and “miscellaneous”. The biliary system is a
branch under “gastroenterology”. The Ishikawa diagram
will be continually expanded and refined based on other
associated symptoms in the individualized context of the
patient. Then, one may ask how a mFMEA approach
would fit in a clinical setting. A mFMEA can provide
inputs into an Ishikawa diagram. Once you have listed the
common causes in an Ishikawa diagram via brainstorming,
discussion, or self-directed learning process, you turn to
mFMEA to explore the potential causes of the human
biliary system (Fig. 1). I would like to elaborate this in the
following paragraphs.
An English scientist, Richard Dawkins, once said,
“Biology is the study of complicated things that have the
appearance of having been designed with a purpose.” The
notable quote underpins many biological and physio-
logical processes within a human body; for example, the
human biliary system. When we review the anatomical
and physiological processes of the biliary system, we
should ask “what is the potential failure and its effect(s)”,
“the associated main clinical features”, and “investigations
that can help a clinician to diagnose” at each anatomical
part and physiological process, and document them in a
mFMEA table (Table 1). The mFMEA table comprises six
columns: “Anatomy and physiology”, “Potential failure or
pathophysiological process”, “Effects of the failure”, “Main
clinical features (symptoms and signs)”, “Investigation”,
and “Note”. We can start with common knowledge found
in the medical literature, and then proceed to search and
extract the relevant medical and surgical cases (generally
known as clinical cases in this article) to fill the mFMEA
table. Establishing a mFMEA can be a teamwork project
or a self-directed learning process, or a mix of teamwork
followed by self-directed learning to continually update it.
For example, the human biliary system is used for illus-
tration (Table 1). Firstly, review the major anatomy and
physiology of the biliary system, and list them in the first
column. The anatomical figure of the biliary system (Fig. 2)
will be helpful to provide visual cues to the physiological
process. At each anatomical part or physiological process,
we should explore what can be the potential failure or
pathophysiological process, the corresponding effect(s),
the resulting clinical features (symptoms and signs), inves-
tigation that can help a clinician to diagnose (in addition
Wong Journal of Medical Case Reports  (2016) 10:85 Page 2 of 12
to the patient’s clinical history and physical examination),
and special note. The treatment is not included in the
table because the treatment option is dependent on the
context of each individual. The note column is used for
highlighting a key message or reminder, for example the
authors of the case of clonorchiasis encourage clinicians
to consider clonorchiasis or opisthorchiasis infection a
possible diagnosis for all undiagnosed abdominal pain
because the infection has the propensity to cause hepatic
fibrosis, liver cancer and cholangiocarcinoma [5]. Also,
the “note” column can be used to record citation of
relevant new or additional cases (see Table 1).
Let us walk through the steps to establish a
mFMEA in Table 1. You may refer to Table 1 and
the references for citations of the relevant cases.
Starting from the gallbladder, we have already known
its common “potential failures” such as cholecystitis,
cholecystolithiasis, and gallbladder cancer. By search-
ing the medical literature, I have found some other
failures such as gallbladder perforation, herniation,
and torsion. The associated effects of the failures in-
clude obstruction, necrosis, and hernia. The main
clinical features range from asymptomatic to abdom-
inal pain with or without jaundice. The relevant in-
vestigations include abdominal ultrasound, computed
tomography (CT) scan, endoscopic retrograde cholan-
giopancreatography (ERCP), and magnetic resonance
cholangiopancreatography (MRCP).
In the cystic duct and common bile duct, obstruction
(caused by gallstone or cancer) and infection are two com-
mon potential failures. In the hepatic duct (intrahepatic
and extrahepatic duct), the potential failures include
obstruction, infection, abscess, cancer, congenital-related
abnormality, for example Caroli’s disease (congenital
dilatation of the intrahepatic bile ducts), choledochal cyst,
and biliary atresia, immune-mediated destruction of the
intrahepatic bile ducts (primary biliary cirrhosis), intense
inflammatory fibrosis of the intrahepatic and extrahepatic
bile ducts (primary sclerosing cholangitis), immunoglobu-
lin G4 (IgG4)-related cholangitis, and abnormality in the
genes encoding for the bile canaliculi formation (progres-
sive familial intrahepatic cholestasis). In addition to
abdominal pain with or without jaundice, other symptoms
and signs include systemic features such as fever, nausea,
vomiting, anorexia, weight loss, anemia, fatigue, pruritus,
steatorrhea, dark urine, and hepatosplenomegaly. Other
investigations include liver function test, liver biopsy, anti-
mitochondrial antibody, and serum IgG4 level according
to the context of the patient.
In the process of bile synthesis, conjugation, and trans-
port, the potential failures are broadly categorized into
Gilbert syndrome, Crigler–Najjar syndrome, Dubin–
Johnson syndrome, and Rotor syndrome. The clinical
features range from asymptomatic to abdominal pain with
or without jaundice. The investigations include special
genetic tests, liver biopsy, and urinary coproporphyrin
level, and plasma sulfobromophthalein depending on the
clinical history of the patient.
Other anatomical parts that relate to the biliary system
include portal vein, hepatic artery, hepatic vein, sphincter
of Oddi, ampulla of Vater, and the pancreas. The potential
failures include iatrogenic injury from surgical procedure,
thrombosis, spasm, stenosis, and cancer. The clinical fea-
tures include Courvoisier sign, legs edema, ascites, fatigue,
anorexia, weight loss, abdominal pain, and jaundice. Special
investigations include Doppler ultrasound of the suprahe-
patic and cava veins, abdominal CT and angiography, and
sphincter of Oddi manometry.
Fig. 1 An Ishikawa diagram for a main presenting complaint of “abdominal pain in the right upper quadrant”. mFMEA modified failure mode and
effects analysis
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in the gallbladder) [6]
Non-obstructive [6] Asymptomatic [6] Abdominal X-ray and
CT [6]
Cholecystitis –usually associated
with obstruction of the outlet
of the gallbladder by a gallstone [6]
The obstruction results in
inflammation of the
gallbladder, and may be
complicated by secondary
bacterial infection [6]




Torsion of the gallbladder
around the cystic duct caused
necrotic gallbladder [7]
Acute onset abdominal pain




Malignancy – e.g. adenocarcinoma [8] The gallbladder tumor invaded
adjacent structures, caused
acute and chronic cholecystitis
with cholelithiasis and
choledochoduodenal fistula [8]
1-month history of episodic
nausea and vomiting, and
epigastric pain on admission [8]
Abdominal ultrasound,
CT, barium study [8]
Perforation – acute on chronic
gallbladder inflammation possibly
due to ischemia and bile stasis
secondary to preoperative fasting
[9]. Perforation – other causes can
be Epstein–Barr virus [10], liver
abscess [11], blunt abdominal
trauma [12], and spontaneous [13]
Bile leaked into the
peritoneum [9]
Umbilical pain and a bluish
discoloration of the skin
around a known umbilical
hernia presumably due to
tracking of bile within the
abdomen [9]
Liver function test, laparotomy
[9]
The patient had spontaneous
acalculous gallbladder perforation
[9]. This condition is rare but critical
Gallbladder herniation: parastomal
[14–18], incisional [19–21],
spontaneous ventral [22, 23],
epigastric [24], transdiaphragmatic
herniation [25]
A midline abdominal hernia
with small bowel loops, and
a parastomal hernia containing
the gallbladder [14]




Gallbladder torsion [17] Torsion of the neck of the
gallbladder with secondary
suppuration leading to
gangrenous changes in the
gallbladder [17]
Abdominal pain [17] Abdominal CT [17] Other case of gallbladder torsion [26],
a new case of gallbladder torsion within
an incisional hernia [27], complete
gallbladder torsion [28], gallbladder
torsion caused acute cholecystitis [7]
A gallstone enters via the Vater
papilla and later increases in
size [29]
Transition of a gallstone in the





Abdominal CT, MRCP [29] Other case: gallbladder-colon fistula
[30] and cholecystogastric fistula [31]
Biliary-enteric fistula e.g. gallbladder-
duodenal fistula [8]
“Spontaneous biliary fistulas have
been associated with gallbladder
cancer; if they are the cause of
cancer, or acomplication of it,
this has not yet been defined.” [8]
1-month history of episodic
nausea and vomiting, and
epigastric pain on admission [8]
Abdominal ultrasound,
CT, barium study [8]
Failure of the cystic bud to
develop in utero [32]
Gallbladder agenesis [32] Reduced appetite, unintentional
weight loss, and a history of
fatty food intolerance [32]
Abdominal ultrasound, CT,
ERCP; preoperative MRCP
should be considered in
cases in which ultrasound
suggests non-visualization
of the gallbladder [32]
Agenesis of the gallbladder could be
made only at laparotomy after having


















Effects of the failure Main clinical features
(symptoms and signs)
Investigationa Note
Cystic duct Obstruction such as due to
gallstone; chronic obstruction
due to other causes [33]
Hydropic gallbladder – accumulation
of mucus in the distended
gallbladder [33]
Abdominal pain in the RUQ [33] Abdominal ultrasound
and MRI [33]
Cystic duct obstruction (+/– cystic
artery strangulation) due to torsion
of the neck of the gallbladder [34]
Leading to mural ischemia/
gallbladder becomes gangrenous,
and may perforate [34]
Epigastric pain with involuntary
guarding and rebound tenderness




Cystic duct infection e.g.
streptococcal infection [36]
Streptococcal toxic shock
syndrome; local necrosis in
the cystic duct due to
microcirculatory failure
as a result of hypoperfusion
and microthrombosis leading
to perforation of the cystic
duct [36]
Abdominal tenderness, rash





* Refer to the case report for the
time-course of the clinical features






the common bile duct) [6]
Non-obstructive [6] Asymptomatic [6] ERCP [6]
Infection: bacterial [38] Cholangitis [38] Charcot’s triad (abdominal pain,




Infection: liver flukes from
consumption of undercooked
contaminated seafood [5]
The metacercariae then excyst and
migrate to the bile duct where
they mature; prolonged infection
may result in cholangiocarcinoma [5]
Abdominal pain, watery stools.
The patients in this case also




after staining the stools
with Giemsa or Ziehl–
Neelsen stains [5]
The authors encourage clinicians to
consider clonorchiasis/opisthorchiasis
infection a possible diagnosis for all
undiagnosed abdominal pain since
the infection has propensity to cause
hepatic fibrosis, liver cancer and
cholangiocarcinoma [5]
Bleeding from the biliary tree is
usually associated with trauma
(can be iatrogenic), cholelithiasis,
vascular disorders, tumors [39]
Hemobilia; tumor invasion into the
intrahepatic bile duct, the tumor may
rupture into the biliary system [39, 40]
Hematemesis and epigastric
pain [39]
Abdominal CT [39] Multislice
CT angiography is increasingly
being used in the
investigation [41]
Hemobilia may present as upper
abdominal pain, gastrointestinal
bleeding, and jaundice in some
patients (22–38 %) [42]





bacteria consistent with Klebsiella
species [43] "Through the portal
circulation, larvae of Ascaris
lumbricoides migrate from the
stomach or small intestine to
the liver and then to the lungs,
where they break out into the
airspaces, migrate up the trachea,
and are swallowed. The larvae develop
into sexually mature adults in the
small intestine where they live and
lay eggs that pass in the feces." [44]
Hepatolithiasis; inflammation in
portal tracts, often with portal
pylethrombophlebitis; patients
with advanced disease have
chronic lesions characterized by
periductal fibrosis [43]
Recurrent pain in the RUQ of
the abdomen [43]
Liver function test, abdominal
ultrasound, CT, ERCP, MRI,
MRCP, blood cultures,
microscopy examination
on stool specimen [43]
The 35-year-old patient was born in
Vietnam and she immigrated to USA in
her early 20s. Multiple large stones in
the common bile duct, the left hepatic
duct, and the left intrahepatic duct. A
wide range of differential diagnoses
were discussed in this article [43].
“Obstruction along the pancreatobiliary
tree may occur if aberrant migration of
larvae or adult worms through the






















Intrahepatic and extrahepatic bile
duct obstruction [46]
Upper abdominal pain, jaundice




Malignancy in the intrahepatic
biliary duct [47]
Intrahepatic cholangiocarcinoma [47] Episodic epigastric pain and
iron-deficiency anemia,
jaundice [47]
Liver function test, full blood
examination, iron studies,




Intrahepatic abscess [11] Intermittent fever, anorexia, and
weight loss [11]
Ultrasound of the liver,
and CT angiogram [11]
Other case [48]
Cholesterol hepatolithiasis [49] Heterotopic pancreatic tissues were
distributed along the wall of the
biliary tract and were composed
of acinar cells and duct elements
without islets of Langerhans [49]
Abdominal pain (45.5 %),
epigastric discomfort (12.0 %),
nausea and vomiting (9.6 %),
bleeding (8.0 %) [49]




excised mass, ERCP [49]
The patient in the case was
asymptomatic [49]
Multifocal congenital dilatations
of the intrahepatic bile ducts [50]
Caroli’s disease (the dilated
intrahepatic ducts, which may
be diffuse or limited, presenting
in a sack form that produces cystic
structures, which communicate
with the biliary tree) [50]
Asymptomatic in this case [50].
Others have reported RUQ
abdominal pain, jaundice, and
recurrent cholangitis [51]






Neonatal biliary obstruction and
cholestasis [52]
Jaundice [52] Urinary urobilinogen combined
with GGT; liver biopsy; diagnosis
of biliary atresia was confirmed
by operative cholangiography
and/or laparotomy findings [52]
Immune-mediated destruction of
the intrahepatic bile ducts [53]
Primary biliary cirrhosis leads to
decreased bile secretion and the
retention of toxic substances within
the liver, resulting in further hepatic
damage, fibrosis, cirrhosis, and
eventually, liver failure [53]
Fatigue and pruritus; unexplained
discomfort in the RUQ of the abdomen;
hepatomegaly; jaundice, portal
hypertension and steatorrhea
may occur in advanced disease;
splenomegaly (uncommon); rarely




which are present in 90–95 %
of patients and are often
detectable years before clinical
signs appear; liver enzymes; liver
biopsy [53]
Intense inflammatory fibrosis of
the intrahepatic and extrahepatic
biliary ducts [54]
Primary sclerosing cholangitis (PSC):
fibrosis involving the common bile
duct, hepatic ducts, and sometimes
the gallbladder; may progress to
secondary biliary cirrhosis [54]
Progressive obstructive jaundice,
pruritus, weight loss, pain (RUQ
or epigastric pain) [54]
Elevation of total and direct
(conjugated) serum bilirubin,
serum alkaline phosphatase
were 3 to 5 times normal;
operative cholangiograms [54]
PSC can be associated with
inflammatory bowel disease. Primary
biliary cirrhosis and sclerosing
cholangiocarcinoma should be ruled
out prior to diagnosing PSC [54]
Extensive IgG4-positive plasma
cells and T-lymphocyte infiltration
of various organs including bile
duct and gallbladder [55]
Systemic fibroinflammatory causing
sclerosing cholangitis [55]
Painless jaundice and weight
loss [55]
CT abdomen, liver function
test, serum IgG4; “ERCP with
intraductal ultrasonography
(IDUS), brush cytology and
endobiliary biopsy would be
helpful” [55]
Another recent case reported that
IgG4-related cholangitis is a rather
uncommon cause of biliary obstruction,



















Effects of the failure Main clinical features
(symptoms and signs)
Investigationa Note
Abnormality in the genes encoding
for canalicular bile formation [57]
Defective bile canaliculi leading to
intrahepatic cholestasis which may
progress to fibrosis and endstage
liver disease (progressive familial
intrahepatic cholestasis) [57]
Progressive jaundice [57] Radiological, laboratory, and
liver biopsy findings [57]
Cystic dilatation of extrahepatic
bile ducts, with or without the
dilatation of the intrahepatic
duct [58]
Choledochal cyst [58] In this case, an antenatal
diagnosis of an abdominal




Liver function test, ERCP, CT
or MRI [6]
Choledochal cyst may be associated
with biliary atresia [59]
Malignancy e.g. SCC at the bifurcation
of the common hepatic duct, and
adenocarcinoma in the common
bile duct [60]
Biliary obstruction leading to
hyperbilirubinemia [60]





Other cases of malignancy at the












Intermittent mild jaundice [64] Genetic testing [64] Reduced expression of bilirubin
UDP-glucuronosyltransferase 1
gene; an autosomal recessive
mode of inheritance was
suggested [63]















This disease is inherited as an
autosomal recessive trait [65]
A defect in the canalicular multispecific
organic anion transporter (cMOAT) gene
(ABCC2/MRP2 superfamily) located at
10q24 [66]
Impaired hepatobiliary transport of
non-bile salt organic anions leading to
chronic conjugated hyperbilirubinemia
(Dubin–Johnson syndrome) [66]
This patient presented with
repeated episodes of jaundice
during illness; other patients
may present with abdominal
pain, fatigue, liver enlargement,
or dark urine [67] [68]
Liver function test, abdominal





This is an autosomal recessive
disorder [67]
Homozygous inactivation of two
adjacent genes SLCO1B1 and SLCO1B3




without abnormal hepatic pigmentation
(Rotor syndrome) [69, 70]. Abnormal
transfer of sulfobromophthalein from
plasma into the liver [70]
Nonhemolytic jaundice [71] Urinary coproporphyrin and
plasma sulfobromophthalein,
genetic testing [70]
This is an autosomal recessive
disorder [70]
Portal vein Iatrogenic injury from surgical
procedure [72]




Another case of portal vein thrombosis
secondary to hyperhomocysteinemia
with pernicious anemia was
reported [73]
Hepatic artery Iatrogenic injury from surgical
procedure [72]
Hepatic ischemia [72], unrecognized
vasculobiliary injury (VBI) can lead to
biliary strictures, cholangitis and liver
atrophy [74]




















Effects of the failure Main clinical features
(symptoms and signs)
Investigationa Note
Hepatic vein Blood clots completely or partially
block the hepatic veins that carry
blood from the liver into the
inferior vena cava [75]
Hepatic vein thrombosis/Budd–Chiari
syndrome [75, 76]
Fatigue, abdominal pain, nausea,
jaundice, hepatosplenomegaly,





and cava veins [76]
Budd–Chiari syndrome is a vascular
complication that can be associated
with Behçet’s disease [76]
Sphincter of
Oddi
Spasm or stenosis of the sphincter
of Oddi (see note in the last
column) [77]












Yaghoobi and Romagnuolo reviewed
recent literature on sphincter of Oddi
dysfunction; little is known about the
etiology of the disease [78]
Ampulla of Vater Adenoma at the ampulla [79] Lithiasis of the bile duct and chronic
pancreatitis [79]
Icterus/jaundice,
and painless swelling of the
gallbladder (Courvoisier sign) [79]
Abdominal ultrasound, CT,
ERCP with biopsy of the
lesion [79]
Adenoma has potential for
malignancy [80]
Pancreas Malignancy (e.g. tumor in the
head of pancreas) [6]
The tumor compresses the common
bile duct and pancreatic duct leading
to hyperbilirubinemia [6]
Anorexia, weight loss, upper
abdominal pain, and jaundice [6]




Red blood cell enzyme (G6PD)
deficiency [82]
The enzyme-deficient red blood cells
are susceptible to hemolysis induced
by certain drugs, bacterial and viral
infections. Excessive hemolysis leads
to increase in unconjugated bilirubin
Jaundice; generalized tonic–
clonic seizure when kernicterus
occurs [82]
Liver function test, serum
G6PD level, G6PD
deficiency phenotyping [82]
G6PD deficiency is an X-linked
recessive disease
Paroxysmal nocturnal hemoglobinuria Prolonged and recurrent red blood cell
breakdown results in increased bilirubin
in the gallbladder. The excess bilirubin
can precipitate bilirubin stones.
Gallstones in the common bile
duct [83]
Jaundice and abdominal pain [83] CT, ERCP, MRCP [83]
Red blood cell membrane defect
resulting in spherical, osmotically
fragile erythrocytes (hereditary
spherocytosis) [84]






showed small and dense
spherocytes; osmotic fragility
test [84]
The patient in the case has coexistence






The excess glucose increases




Hepatomegaly and pain in
the RUQ [85]
Ultrasound abdomen, liver
function test, and liver
biopsy [85]
This table is neither exhaustive nor comprehensive. For instance, it has not included drug-induced liver injury, and various infective causes such as hepatitis. It is meant to be a framework for discussion and illustration in this
article. It can be deployed and continually updated by clinicians for their own use. aIn addition to a patient’s clinical history and physical examination findings. CT computed tomography, ERCP endoscopic
retrograde cholangiopancreatography, G6PD glucose-6-phosphate dehydrogenase, GGT gamma-glutamyltransferase, IDUS intraductal ultrasonography, IgG4 immunoglobulin G4, MRCP magnetic resonance












The relevant potential failures of the hematological
process, which is not restricted to a particular anatomical
structure, include glucose-6-phosphate dehydrogenase
(G6PD) deficiency, paroxysmal nocturnal hemoglobinuria
(PNH), and hereditary spherocytosis. These abnormalities
result in excessive hemolysis of red blood cells leading to
hyperbilirubinemia. The clinical features include anemia,
jaundice, splenomegaly, and kernicterus (in serious cases).
The special investigations include serum G6PD level,
genetic test, peripheral blood smear, and spherocyte os-
motic fragility test.
An example of endocrinological condition has
been reported in the New England Journal of Medi-
cine - A patient with poorly controlled diabetes melli-
tus has excessive glucose in the blood leading to an
increase in glycogen storage in the liver and inhib-
ition of glycogenolysis resulting in glycogenic hepato-
pathy. The condition is manifested as hepatomegaly
and pain in the RUQ of the abdomen.
After establishing the mFMEA in Table 1, I can
update the relevant Ishikawa diagram for “pain in
the RUQ of the abdomen” (Fig. 1) to include the de-
tailed inputs for the “biliary pathology” as shown in
Fig. 3.
There are many sources of clinical cases such as:
 Journal of Medical Case Reports
 BMJ Case Reports
 New England Journal of Medicine
 Many other BioMed Central Open Access journals,
for example BMC Surgery
How to keep a mFMEA table up to date.
 Set automatic notification when a relevant research
or medical case report is published, for example
setting a “search alert” in Journal of Medical Case
Reports. This can be easily done by using the
advanced search function, perform your search, and
save the search history that you want to activate
“search alert”. You can always go back to your
“saved searches” to refine your search algorithm.
 Review an article and evaluate whether it fits into an
anatomical or physiological part in a specific
mFMEA, for example the biliary system. If a clinical
case adds new findings in terms of
pathophysiological process, unique clinical features,
or investigation method, it should be added into the
relevant columns in the mFMEA. This mFMEA
process will collate and enrich the body of evidence
for a specific clinical condition over time.
 You may attach a copy of the case report in the
citation as a file attachment in an electronic
database such as EndNote software. This will
provide handy access to the references.
 The relevant main clinical features in the mFMEA,
for example RUQ pain (or abdominal pain) can be
extracted and reflected in the relevant Ishikawa
diagram (see Figs. 1 and 3)
Advantages of weaving clinical cases into a mFMEA.
 mFMEA is a methodology that collates common,
important, and critical (but rare) potential causes of
a clinical condition.
 Studying clinical cases can reinforce clinicians’
reasoning and diagnostic skills, and clinical
experience.
 Clinicians may not have the opportunity to be
involved in caring for patients with various potential
“failure modes” of a clinical condition. Studying
clinical cases and weaving them into a mFMEA will
provide the opportunity to substantiate the lack of
experience.
Fig. 2 The human biliary system. Image courtesy of Visible Body (www.visiblebody.com)
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 Medical educators can select relevant clinical cases
from a mFMEA to set the scenario for teaching a
relevant topic.
 Medical educators should encourage medical
students to attempt the approach of identifying the
potential pathophysiology and diagnosis before
providing the answer. It is acceptable to err in role
playing the clinical case, and learn from the errors!
 Interactive teaching and learning using clinical cases
are more engaging and interesting compared to sole
didactic teaching.
 Medical educators can relate the clinical cases to a
relevant Ishikawa diagram and mFMEA.
 GPs/family physicians may use a mFMEA to identify
and manage critical but rare conditions. They may
not need to go into the details of certain
pathophysiological processes which may not be
relevant to their role as a GP/family physician, for
example different types of gallbladder herniation. By
contrast, surgeons could be interested to find out
the various gallbladder herniations and surgical
interventions reported in the literature to compare
and enhance their clinical experiences.
Concluding remarks
The mFMEA can be deployed as a tool to generate in-
puts for an Ishikawa diagram. Clinicians may apply the
tool in their clinical reasoning process; while medical ed-
ucators may select relevant clinical cases to set the sce-
narios to teach and facilitate a discussion among medical
students, and relate the clinical cases back into a rele-
vant mFMEA and Ishikawa diagram.
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